Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice job NSX! Have a great weekend. All of us know Monday is a Holiday!
Do you think NITE signaled you back with the 262,222 bid?
Choo Choo!!!
IMITATION is the greatest form of flattery
Good Morning CELZrs! Up early to fly to SoCal. I'll check back in when I land later this morning. Good Luck to All!
BS, There is no P&D here. Just good DD!
No what you own and Learn the Bull$hit around. If it stinks, it's BS...
Me too, I fly tomorrow morning. Hopefully this will continue!
I think I said it in this post that you were wishing you could have bought lower when it was $.06, well it's lower!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143115069
I agree, sitting back with my popcorn!
One He!! of a post Star!
THE OS IS NOT SCARY AT ALL!! Do your own DD folks!
I'm a LONG investor on CELZ and I’m not going anywhere. I have not sold a single share even in the drop from 7 cent to here. CELZ is ROCK SOLID. Are there less than warm n fuzzies with the reality of funding a startup doing peer reviewed research and filing 13 PATENTS? Sure there are. Do we all wish they could of/would of crowd-sourced their cash needs from us faithful who had it to lend instead of obtaining funding from the loan sharks? Of course. BUT, in spite of the traditional ways of financing OTC startup operations, CELZ is doing something remarkable. They obtained 13 loans through June 30, 2018. They have already paid or converted ~ 8 of 13 and the last loan was a traditional non-convertible business loan at a respectable 8% interest rate (June 27th loan.) - They also PAID OFF ALL 2017 LOANS totaling $620,000 by June 30th. And then there's that whole other thing called SIGNING UP DOCTORS UNDER LICENSE and then signing a national Russian Contract, and then, oh yeah, Caverstem-Switzerland.com anybody? That's right...only the finest minds and conservative people on the planet and their top urologist has signed up to be THE agent for training all European docs signing up to be Caverstem providers.
Please understand that all posts related to OS increases by CMTH being TOXIC and AWFUL for the stock just simply aren't true. IF CELZ wasn't creating amazing value and actually generating revenues then it would be pretty bad. BUT, CELZy's value is growing in spades! IT IS! And the 10Q shows proof of concept turning into proof of revenue. The 10Q actually says so on page 35 of 39 if printed from SEC website: ..."The decrease in cash used in operations was primarily related to a $48,466 increase in accounts payable, a $20,000 pre-payment from a new Caverstem customer, and $38,300 lower payments towards an outstanding balance of management fees payable to a related party." Caverstem matters more than making a phone call or snapping a picture and I guarantee at least half of the world's population would agree with that statement.
So, back to the subject line regarding OS not being scary...
CELZ's Outstanding Shares in Dec '17: 106,323,582 PPS was $0.0135
CELZ's Outstanding Shares on Mar '18: 188,131,817 PPS avg $0.0025
CELZ's Outstanding Shares on Jun '18: 623,924,281 PPS avg $0.035
DECEMBER TO JUNE THE PPS WENT UP 1,592%. The OS INCREASED by 517M shares or 487% Ask yourself this question: Does it matter if the number of shares increase by a trillion shares if YOUR (now diluted) shares actually go up in 1,592% in value per share? The answer is not one bit. What does all those new owners in the company do? They create much higher LIQUIDITY which will help STABILIZE PPS. Increasing OS can be really quite good if you can get past the nitty gritty and the scary fear inducing misrepresentation.
If the 93 Million in potential dilution were still fully in play (per fact found in Note 5 of the 10Q) and were to convert this month, they would have an OS at ~ 810M shares. IF the share price were to increase on that increase like it did in Q2 of 2018 (1,580% INCREASE in PPS with 435M OS increase) than the next soon to be PPS could easily be ~ $0.40 cents or more. Is this scenario more likely than a "toxic bankruptcy"? Think for yourself. They signed and publicly announced 7 new doctors signed up after the AUA conference and they have 50 domain names secured ALREADY. That doesn't include Russia or Europe. And many of us LONGS believe that International is worth MORE than Domestic. So, for me personally, I think CELZ is easily worth 50 cents PPS on it's (IP) intellectual property alone. Factor in Revenue from all that crazy licensing and kit selling activity and the PPS is EASILY OVER A DOLLAR.
If you are patient long enough...you can water in a sieve. You just have to wait for it to freeze. Wait folks, CELZ is going to be worth the carry.
AIMHO. GOOD LUCK TO TRUE LONGS!
CELZ patents and the 10Q:
What exactly does IT mean? Is there ANY truth to comments about the little value of the patents? Well, if I were just now showing up to the iHub and didn’t know any better and read his post, and then checked the 10Q, I might actually believe if I were a green horn in the patent world. Why? Because the 10Q does say that the ED patent only has a “carrying value” of $75,890. Whoa, that seems very low indeed! Maybe something knows what’s they're talking about after all.
Stop the presses. Let’s make sure to point out the next sentence in that 10Q Note 2 – Licensing Agreements section as it relates to the ED Patent: “The Company expects to amortize approximately $9,972 annually through 2026 related to the patent costs.” Okay, now for a little simple math…what is $9,972 times 7.5 years (remaining patent life)? That be $74,790. That’s close enough to the FV (face value) of $75,890 to be considered a wash.
So, what’s the point here? The point is that all of the patent “values” that are reported in the 10Q are the ACTUAL COSTS they’ve paid to either secure via licensing the patents or prosecute the patent applications. They get to amortize these just like if they bought an SUV to put Realtor signs in the back of to sell a house. Or that dough mixer in a restaurant. This is the dry and boring world of accounting folks. Nothing titillating. If they were to indeed value the patents, it would HAVE TO BE IN GOODWILL as special provisions would have to be taken in the reporting as that is an INTANGIBLE ASSET.
You cannot report according to GAAP (Generally accepted accounting principles) the “value” of an intangible asset as a “hard” asset. Any value associated with a patent is (for better or worse) tied to the revenues it generates. In accounting though, the “matching principle” requires there to be a link between revenue and expenses. In this case, they get to, have-to, do, report the costs of getting the patents but don’t get to report what they consider the “fair” value to be and when you’re pre-revenue with an IP portfolio, you don’t get to be “fairly” valued at all (no revs to support the narrative). It’s an imbalance because it is incredibly hard to say what value an intangible asset has at any given moment and accounting likes everything to be super “accountable” in the reliable measure of a thing.
Last issue…patent’s “ALL EXPIRE SOON” he says…well, fact check says ED has 7.5 YEARS (and it’s they’ve got it commercialized TODAY!), Lower Back Patent is good until 2037 (19yrs), neither of which seem like “soon” to me. Plus, they have filed numerous (I think 13!) pat apps in 2017 that will all get 15-20 yrs of life when issued (I say when, not if..they are an IP A-team).
Fingers crossed we get an 8k or PR soon! Good luck Longz. Go CELZ$$$$
NO FDA APPROVAL NEEDED FOR CELZ
It has been proven over and over and over again! These are the patient's own Stem Cells being put back in their own body. The FDA doesn't have to approve it.
If the FDA needed to approve it, what are all these Doctors doing signing up with Caverstem? Are all of these Doctors stupid?
I see the same thing. Watch out for the walk down...
Nice to have you back NSX!
Unknown, all I know is the results from the clinical trials should be coming out at the end of August. Then we head to the AUA in Chicago.
CaverStemTM Clincal Trial with LA BioMed:
As per our contract with LA BioMed, the results will be made available 12 months after the last patient was enrolled. This will occur the end of August 2018. Once the data is received, analyzed and peer reviewed, the results will be jointly released by our company and LA BioMed.
CaverStemTM Clincal Trial with LA BioMed:
As per our contract with LA BioMed, the results will be made available 12 months after the last patient was enrolled. This will occur the end of August 2018. Once the data is received, analyzed and peer reviewed, the results will be jointly released by our company and LA BioMed.
From The SHAREHOLDER UPDATE
https://finance.yahoo.com/news/shareholder-creative-medical-technology-holdings-214300226.html
Just in case people can't click the link, I'll post it below.
PHOENIX, Aug. 14, 2018 /PRNewswire/ -- (OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its corporate activities.
Debt: Since our last 8k on debt reduction an additional $268,858.00 has been extinguished.
CaverStemTM: Domestic recruitment, vetting and training of physicians on the CaverStemTM program for the use of the patients own stem cells for the treatment of erectile dysfunction is continuing post AUA Conference in May 2018.
We wish to welcome some of the physicians in the CaverStem program;
Elias Said, MD and Mark Bieri, MD located in Las Cruces, NM. (caverstem-nm.com)
Victor Liu, MD located in San Francisco, CA, (caverstem-sanfrancisco.com)
David Brown, MD located in San Diego, CA, (caverstem-sandiego.com)
Barton Wachs, MD located in Orange County, CA, (caverstem-oc.com)
Sheldon Freedman, MD located in Las Vegas, CA, (caverstem-lasvegas.com)
Perinchery Narayan, MD at North Florida Urology with offices in Orlando, Ocala, Gainsville, St. Augustine and Palatka, FL. (caverstem-northflorida.com)
CaverStemTM International:
Implementation of our contract with Promo Med continues to move forward. We are also currently working with Dr. Alexander Buchmann with Alto Uro in Bern Switzerland to establish the CaverStemTM program in Switzerland, Germany and Austria. We are pleased with the opportunity to work with a highly regarded physician such as Dr. Buchmann to expand CaverStemTM in Europe.
CaverStemTM Clincal Trial: As per our contract with LA BioMed, the results will be made available 12 months after the last patient was enrolled. This will occur the end of August 2018. Once the data is received, analyzed and peer reviewed, the results will be jointly released by our company and LA BioMed.
American Urological Association Regional Conference: We will be exhibiting at this conference in Chicago September 5-9, 2018.
StemSpineTM: This patented technology for the use of stem cells for the treatment of degenerative disc disease represents the entry into a multi-billion dollar market. The StemSpineTM model is the use of stem cells from bone marrow from the as with the CaverStemTM program.
AmnioStemTM: The AmnioStemTM program is meeting our expected development milestones.
Stroke, Medical Wasting, Radiation Toxicity and other patents: Our intellectual property portfolio is meeting our expected milestones and we intend to release information as our progress continues.
Summary: We have faced challenges but we continue to grow our programs strategically and efficiently. We are optimistic with the progress and fundamentals of our company.
We wish to thank our shareholders for their continued support.
AUA Conference in Chicago
American Urological Association Regional Conference: We will be exhibiting at this conference in Chicago September 5-9, 2018.
CAVERSTEM CLINIC TRIAL RESULTS!
CaverStemTM Clincal Trial: As per our contract with LA BioMed, the results will be made available 12 months after the last patient was enrolled. This will occur the end of August 2018. Once the data is received, analyzed and peer reviewed, the results will be jointly released by our company and LA BioMed.
Caverstem Campaign Videos
https://www.youtube.com/channel/UCqXes01LJZdZUYZoGVSoHDw
Video of the Caverstem procedure performed by Dr. Gershman
https://www.youtube.com/channel/UCpib3ccLHGOfmSZWD85vLvw
If you don't think this is manipulated, watch this walk down. This is ridiculous! The buying gets it back up to $.026, momentum gets going and then BAM, MMs bring the walk back down. We need to keep the pressure on them.
The next 10Q with the revenue from the Doctors that have signed up and possible procedures being performed from 7/1-9/30. Those are unknown. We know they signed 7 doctors. At $20,000 per doctor, that's $140,000 in revenue. How many procedures will they perform?
What about Russia? That was signed in July. That will come out in the next 10Q as well.
If these aren't reasons to stay, along with the Trial Results and the AUA in Chicago, I don't know what is.
THE OS IS NOT SCARY AT ALL!! Do your own DD folks!
I'm a LONG investor on CELZ and I’m not going anywhere. I have not sold a single share even in the drop from 7 cent to here. CELZ is ROCK SOLID. Are there less than warm n fuzzies with the reality of funding a startup doing peer reviewed research and filing 13 PATENTS? Sure there are. Do we all wish they could of/would of crowd-sourced their cash needs from us faithful who had it to lend instead of obtaining funding from the loan sharks? Of course. BUT, in spite of the traditional ways of financing OTC startup operations, CELZ is doing something remarkable. They obtained 13 loans through June 30, 2018. They have already paid or converted ~ 8 of 13 and the last loan was a traditional non-convertible business loan at a respectable 8% interest rate (June 27th loan.) - They also PAID OFF ALL 2017 LOANS totaling $620,000 by June 30th. And then there's that whole other thing called SIGNING UP DOCTORS UNDER LICENSE and then signing a national Russian Contract, and then, oh yeah, Caverstem-Switzerland.com anybody? That's right...only the finest minds and conservative people on the planet and their top urologist has signed up to be THE agent for training all European docs signing up to be Caverstem providers.
Please understand that all posts related to OS increases by CMTH being TOXIC and AWFUL for the stock just simply aren't true. IF CELZ wasn't creating amazing value and actually generating revenues then it would be pretty bad. BUT, CELZy's value is growing in spades! IT IS! And the 10Q shows proof of concept turning into proof of revenue. The 10Q actually says so on page 35 of 39 if printed from SEC website: ..."The decrease in cash used in operations was primarily related to a $48,466 increase in accounts payable, a $20,000 pre-payment from a new Caverstem customer, and $38,300 lower payments towards an outstanding balance of management fees payable to a related party." Caverstem matters more than making a phone call or snapping a picture and I guarantee at least half of the world's population would agree with that statement.
So, back to the subject line regarding OS not being scary...
CELZ's Outstanding Shares in Dec '17: 106,323,582 PPS was $0.0135
CELZ's Outstanding Shares on Mar '18: 188,131,817 PPS avg $0.0025
CELZ's Outstanding Shares on Jun '18: 623,924,281 PPS avg $0.035
DECEMBER TO JUNE THE PPS WENT UP 1,592%. The OS INCREASED by 517M shares or 487% Ask yourself this question: Does it matter if the number of shares increase by a trillion shares if YOUR (now diluted) shares actually go up in 1,592% in value per share? The answer is not one bit. What does all those new owners in the company do? They create much higher LIQUIDITY which will help STABILIZE PPS. Increasing OS can be really quite good if you can get past the nitty gritty and the scary fear inducing misrepresentation.
If the 93 Million in potential dilution were still fully in play (per fact found in Note 5 of the 10Q) and were to convert this month, they would have an OS at ~ 810M shares. IF the share price were to increase on that increase like it did in Q2 of 2018 (1,580% INCREASE in PPS with 435M OS increase) than the next soon to be PPS could easily be ~ $0.40 cents or more. Is this scenario more likely than a "toxic bankruptcy"? Think for yourself. They signed and publicly announced 7 new doctors signed up after the AUA conference and they have 50 domain names secured ALREADY. That doesn't include Russia or Europe. And many of us LONGS believe that International is worth MORE than Domestic. So, for me personally, I think CELZ is easily worth 50 cents PPS on it's (IP) intellectual property alone. Factor in Revenue from all that crazy licensing and kit selling activity and the PPS is EASILY OVER A DOLLAR.
If you are patient long enough...you can water in a sieve. You just have to wait for it to freeze. Wait folks, CELZ is going to be worth the carry.
AIMHO. GOOD LUCK TO TRUE LONGS!
October, 2017: Safety established, supported, and commercialization planned
This was one of NSX's posts. I think it is important.
Creative Medical Technology Holdings Announces Commercialization of patented Stem Cell Procedure for Erectile Dysfunction.
Trial Results Support Initiation of Urologist Outreach and Commercialization
October 18, 2017 Phoenix, AZ, Creative Medical Technology Holdings (OTCQB – CELZ) announced today completion of the safety data analysis on 20 patients with pharmacologically-resistant erectile dysfunction treated with the Company’s patented CaverStem TM procedure.
Here to stay with results coming out in less than 3 weeks, around the time for AUA in Chicago 9/5-9/9
I'm long here too. I wish NSX would come back.
Nice Job Monte!
What do you think all the Patents are worth? $20mil, $30mil, $100+mil
They have only started on Caverstem. That has the potential for $100mil or more. Do the math and you will figure it out. With that thought in mind, if Caverstem makes this company worth $100mil, divide that by the 717mil shares and you get the stock price. It’s $0.1394….
Even if we go higher, let’s say to 810mil shares. Divide that and you’ll get the stock price. It’s $0.1234….
Let’s say Caverstem is only worth 20mil. Divide that by the 810mil shares and you get $.02469. If it is 717mil shares, the price is $.02789… Where is the share price today? Within that range? Why? I think you can see why we’re here right now.
Will CELZ/CMTH payoff some debt with the revenue that’s being generated? Who knows? They’re doing their best to stay in business. They have a Fortune 500 Sales Executive flying all over to sign these deals. They’re accumulating debt, but with the bright future. You can jump ship or stay on board, your choice.
I’m hopeful the PEER REVIEWED Trial Results will come back with the 90% positive outcome we have been hearing about. I’m hoping CELZ signs on more doctors at the AUA conference in Chicago. When will we find this out? Probably not until after 9/30. It will be in the next 10Q, or a shareholder announcement in an 8k.
Will the share price go lower? It could. I don’t know. What I do know is I’m long here and I’m waiting for some news. I think the Caverstem procedure is a great one and once the doctors are consistently doing the procedures and advertising, this will take off.
This might take a little bit to get out, but I’m trying to figure things out here too.
We hear CELZ had 4k in revenue and 10mil in debt in the 10Q, which ended on 6/30. They had to convert some debt into shares. We went from 623mil shares to 696mil shares, now we’re at 717mil shares. CELZ has 3bil shares to play with. I don’t think they want to keep paying off their debt this way.
After 6/30, they made a deal with Russia, and signed multiple doctors in the US. They have also made deals with Switzerland, Germany and Austria by signing a doctor there. I know they’re working on other countries. The US signed doctors were a total of 7. One of the 7 has 4 offices in North Florida. This can all be found here: https://finance.yahoo.com/news/shareholder-creative-medical-technology-holdings-214300226.html
All of this proves to me that they’re generating money. If the 7 doctors in the US each paid $20,000 to use the Caverstem TM method, then that is $140k generated after 6/30. Between 7/1 and 9/30, how many procedures do you think these 7 doctors are doing plus Gershman? If they get up and running, the raw estimate is 5 a day. I know the New Mexico offices are being re-done to accommodate the 2 doctors there. Are they doing this because CELZ is going broke and this won’t make any money? Is Russia on board with this because this is a bad choice?
Other items, CELZ has all the Caverstem domain names. They are building an infrastructure and they’ll use the doctors to do their own commercials. Have you seen Caverstem commercials? They’re right here: https://www.youtube.com/channel/UCqXes01LJZdZUYZoGVSoHDw
Have you seen the procedure? It is right here: https://www.youtube.com/channel/UCpib3ccLHGOfmSZWD85vLvw
I think General Grievous contacted Gershman in Southern California and received a reply back from Olga. She stated the procedure is $3800. We believe $1600 goes to CELZ per procedure. How many procedures has Gershman done since 6/30? We’ll find out in the next 10Q.
And this is just for Caverstem. They’re still working on AmnioStem and SpineStem, along with their other 9 patents THAT HAVEN’T EXPIRED!
What do you think these doctors are going to do when they can do AmnioStem and SpineStem? How much can be generated here?
Simple math – 7 US Doctors - $20k each - $140K generated. If they can do 5 procedures a day, 5 days a week, that would 175 procedures a week. Let’s go conservative and say 100 a week, generating $160,000 a week for CELZ. Let’s say they’re up and running in September only, we’ll assume it took them July and August to get up and running and could only do procedures in September. We have 4 weeks in September. That would generate $640,000. Between these 2 totals, that would be $780k of revenue in this quarter. Do you think they could use part of this to pay off the $125k on August 22? This is for the US only! How many procedures will Russia be doing?
I’m not expecting this stock to explode overnight. It is hard to watch it go down the way it has, but if you thought this procedure and these doctors could get up and running in 1-2 weeks, you’re kidding yourself.
I remember back when this stock was at $.06 and everyone was wishing they could have bought more shares at a lower price. HERE IS THE LOWER PRICE.
"CELZ is a stock with a past that has featured a litany of sudden rips to the upside. In addition, the name has registered increased average transaction volume recently, with the past month seeing greater than 1100% above its longer-run average levels." - https://oracledispatch.com/2018/02/18/new-life-emerges-creative-medical-technology-holdings-inc-otcmktscelz/
CELZ patents and the 10Q:
What exactly is HE talking about? Is there ANY truth to his comments about the little value of the patents? Well, if I were just now showing up to the iHub and didn’t know any better and read his post, and then checked the 10Q, I might actually believe him if I were a green horn in the patent world. Why? Because the 10Q does say that the ED patent only has a “carrying value” of $75,890. Whoa, that seems very low indeed! Maybe HE knows what’s he’s talking about after all.
Stop the presses. Let’s make sure to point out the next sentence in that 10Q Note 2 – Licensing Agreements section as it relates to the ED Patent: “The Company expects to amortize approximately $9,972 annually through 2026 related to the patent costs.” Okay, now for a little simple math…what is $9,972 times 7.5 years (remaining patent life)? That be $74,790. That’s close enough to the FV (face value) of $75,890 to be considered a wash.
So, what’s the point here? The point is that all of the patent “values” that are reported in the 10Q are the ACTUAL COSTS they’ve paid to either secure via licensing the patents or prosecute the patent applications. They get to amortize these just like if they bought an SUV to put Realtor signs in the back of to sell a house. Or that dough mixer in a restaurant. This is the dry and boring world of accounting folks. Nothing titillating. If they were to indeed value the patents, it would HAVE TO BE IN GOODWILL as special provisions would have to be taken in the reporting as that is an INTANGIBLE ASSET.
You cannot report according to GAAP (Generally accepted accounting principles) the “value” of an intangible asset as a “hard” asset. Any value associated with a patent is (for better or worse) tied to the revenues it generates. In accounting though, the “matching principle” requires there to be a link between revenue and expenses. In this case, they get to, have-to, do, report the costs of getting the patents but don’t get to report what they consider the “fair” value to be and when you’re pre-revenue with an IP portfolio, you don’t get to be “fairly” valued at all (no revs to support the narrative). It’s an imbalance because it is incredibly hard to say what value an intangible asset has at any given moment and accounting likes everything to be super “accountable” in the reliable measure of a thing.
Last issue…patent’s “ALL EXPIRE SOON” he says…well, fact check says ED has 7.5 YEARS (and it’s they’ve got it commercialized TODAY!), Lower Back Patent is good until 2037 (19yrs), neither of which seem like “soon” to me. Plus, they have filed numerous (I think 13!) pat apps in 2017 that will all get 15-20 yrs of life when issued (I say when, not if..they are an IP A-team).
Fingers crossed we get an 8k or PR soon! Good luck Longz. Go CELZ$$$$
When does news usually come out for CELZ? We can see their pattern. It is usually EARLY IN THE MORNING or AFTER THE BELL on Tuesdays/Thursdays
If you're prepared for the $107k payoff, according to the 10k, on August 22. Do you think they could put something out after today's bell?
Just my opinion....do what you want!
Chugga, Chugga, Chugga, CHOO CHOO! I hear that train coming!
Can't wait for the news tomorrow, August 22, where the $107k note is paid in full! Then we get news from the trials after August 28, timed perfectly with the AUA Conference in Chicago on September 5.
GO CELZ!
According to the 10Q, that's when the $106,000+ is due, if I read that correct. If they pay that off, they have revenue. The $106,000+ that was borrowed to pay back another debt will be paid off August 22.
Then we need the results at the time of the AUA in Chicago.
The next few weeks should be exciting! That will lead us into the next Q results which will bring us to December.
I agree with NSX, CF, GG and others. Ignore the day to day. Know what you own, have patience.
Good Morning CELZrs! Let's have a great week! August 22 should have some good news, then onto the results at the end of the month. Momentum into September.
I'm just guessing here GG, but I think the 34 mil+ shares for the $40k+ was promised back in March and came through in August for the conversion. The share price was around $.002 at the time. Half price for the Conversion
The 5 mil+ shares for the $116k+ was a negotiating tactic based on the share price on August 8. At that time, the price was hovering around $.04. The negotiation for the share price was half price.
Again, just guessing here, but I think this is what has taken our stock price down to these levels. The good news is they're expecting cash flow to payback the $106,000 loan on August 22.
Hopefully, going forward, they will repay the loans instead of converting them to shares.